News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Northwest European gasoline refining margins rose to $52 per barrel after roughly 20,000 metric tons of E5/E10 gasoline barges traded among traders and refiners.
  • Ukraine and Russia reportedly agreed not to target each other's energy infrastructure, lowering near-term regional energy risk.
  • Constellation Energy's pullback appears driven by timing and financing fears, despite Calpine scale, hyperscaler PPAs, and raised guidance, implying upside.
  • Richtech Robotics offers a speculative swing trade with substantial cash, board buybacks, and trade-show catalysts but material governance and profitability risks.
  • Toll Brothers opened sales for 43 Redondo Beach luxury townhomes priced from $2 million, signaling strength in coastal high-end housing demand.
  • Northrop Grumman and the U.S. Air Force completed vertical assembly of the Sentinel missile, advancing toward a 2027 flight test and defense readiness.

Latest Articles

Global Payments: Time to Lean Against the Pessimism

Global Payments: Time to Lean Against the Pessimism

Global Payments (GPN) is trading below recent highs despite solid cash generation, a large buyback and favorable industry fundamentals. The market is pricing significant execution risk; we think upside to the mid-high $90s is a realistic 45-trading-day outcome. Actionable long trade with clear entry, stop and target.

AIM ImmunoTech CEO Highlights Biodefense and Military Force Protection in Newly Published ‘Breaking Defense’ Article

AIM ImmunoTech CEO Highlights Biodefense and Military Force Protection in Newly Published ‘Breaking Defense’ Article

AIM ImmunoTech's CEO, Thomas K. Equels, published an article emphasizing the importance of integrating broad-spectrum antiviral countermeasures like Ampligen® into military biodefense strategies. The article highlights preclinical research demonstrating Ampligen's potential efficacy against Ebola and SARS-related viruses, advocating for early gover…

RoboStrategy, Inc. Updates Net Asset Value as of July 31, 2026

RoboStrategy, Inc. Updates Net Asset Value as of July 31, 2026

RoboStrategy, Inc., a Nasdaq-listed closed-end fund focused on robotics and physical AI private companies, announced a NAV per share increase to $11.32 as of July 31, 2026, marking a 10.33% rise from June 30, 2026. The fund holds equity in innovators like Figure AI, Apptronik, and Dyna Robotics, reflecting robust growth and investor confidence in t…

ENvue Medical Secures Equity Financing Facility of Up to $50 Million to Support Commercial Growth, Technology Expansion and Strategic Acquisitions

ENvue Medical Secures Equity Financing Facility of Up to $50 Million to Support Commercial Growth, Technology Expansion and Strategic Acquisitions

ENvue Medical, a US-based medical technology firm specializing in enteral care solutions, announced an equity financing facility of up to $50 million with an institutional investor. The funding aims to enhance the company's financial flexibility to support commercial expansion, accelerate adoption of its feeding tube navigation system, advance next…

Beeline CEO Invests Additional $500,000 in Company, Reinforcing Confidence in Growth Strategy and Execution

Beeline CEO Invests Additional $500,000 in Company, Reinforcing Confidence in Growth Strategy and Execution

Beeline Holdings, a technology-driven mortgage lender, announced that CEO Nicholas Liuzza invested $500,000 via a convertible note, reflecting confidence in the company’s strategy and recent progress. The note will convert into shares at a price not below $1.50 or the market VWAP, aligning leadership interests with shareholders. The company is purs…

Buy the Dip in SpaceX: Growth Is Intact, Sentiment Isn’t

Buy the Dip in SpaceX: Growth Is Intact, Sentiment Isn’t

SpaceX faces intense skepticism today, but the company's differentiated launch economics, Starlink revenue runway and Starship-enabled TAM expansion argue for a patient, defined-risk long. This trade idea lays out an entry at $85.00, a stop at $66.00 and a $140.00 target over a long-term (180 trading days) horizon.

Odysight.ai to Participate in Upcoming Investor Conferences

Odysight.ai to Participate in Upcoming Investor Conferences

Odysight.ai Inc., an AI-driven predictive maintenance solutions provider for defense and industrial sectors, announced its management team's participation in key investor conferences during Q3 2026, including the Sidoti Virtual Micro-Cap Conference and the H.C. Wainwright 28th Annual Global Investment Conference, to showcase its technology and enga…

Founder Group Limited Secures Second Aquaculture Contract, a US$1.4 million 1.78 MW rooftop system for a Kedah shrimp Farm

Founder Group Limited Secures Second Aquaculture Contract, a US$1.4 million 1.78 MW rooftop system for a Kedah shrimp Farm

Founder Group Limited has signed a RM5.58 million (US$1.37 million) contract to build a 1.78 MW rooftop solar system for a shrimp farming and processing facility in Kedah, Malaysia. This marks the company's second major aquaculture-focused renewable energy project, supporting Malaysia's growing aquaculture sector and national renewable energy goals…

Aprea Therapeutics Announces Second Quarter 2026 Financial Results

Aprea Therapeutics Announces Second Quarter 2026 Financial Results

Aprea Therapeutics reported Q2 2026 financial results and provided updates on its clinical-stage oncology programs. Enrollment in the Phase 1 ACESOT-1051 trial of oral WEE1 inhibitor APR-1051 is accelerating with expansion to more clinical sites. Early data show promising anti-tumor activity and manageable tolerability. The company plans to advance…

Exyn Technologies Forms Defense Advisory Board, Names Former Trump Administration Pentagon Official and Green Beret Andrew Knaggs as Inaugural Member

Exyn Technologies Forms Defense Advisory Board, Names Former Trump Administration Pentagon Official and Green Beret Andrew Knaggs as Inaugural Member

Exyn Technologies announced the formation of a Defense Advisory Board to enhance its efforts in securing and scaling autonomous technology programs with the U.S. and allied defense sectors. Andrew Knaggs, a former Deputy Assistant Secretary of Defense and decorated Green Beret, has been named the inaugural member. This move supports Exyn's recent g…

Propanc Biopharma Highlights Differentiated Proenzyme Therapy PRP as a Potential Therapy of Choice Against RAS-Driven Cancers

Propanc Biopharma Highlights Differentiated Proenzyme Therapy PRP as a Potential Therapy of Choice Against RAS-Driven Cancers

Propanc Biopharma highlights its lead candidate PRP, a novel proenzyme therapy aiming to treat aggressive, treatment-resistant RAS-driven cancers by promoting cancer cell differentiation and reversing metastatic processes. PRP differs from current RAS inhibitors by targeting cancer stem cells and epithelial-mesenchymal transition rather than solely…

Cloudastructure Expands Multifamily Footprint With Third Deployment for Longtime Baltimore Developer

Cloudastructure Expands Multifamily Footprint With Third Deployment for Longtime Baltimore Developer

Cloudastructure, Inc., a NASDAQ-listed AI surveillance and security analytics company, has been awarded the installation contract for a third multifamily property with a longtime Baltimore developer. The initial phase includes installing approximately 70 cameras, with advanced AI surveillance and remote guarding services expected to be utilized aft…

Dyadic Announces Second Quarter 2026 Financial Results Accelerating Commercialization Momentum Across Key Business Areas

Dyadic Announces Second Quarter 2026 Financial Results Accelerating Commercialization Momentum Across Key Business Areas

Dyadic International, Inc. reported its Q2 2026 financial results showing continued commercialization progress across recombinant proteins and strategic OEM partnerships. The company advanced multiple product shipments, scale-up agreements, and global health initiatives using its proprietary C1 biomanufacturing platform. Despite increased costs and…

Powerus, Aureus Greenway Holdings Inc. announce $2.51M purchase order for drones in support of Department of War program

Powerus, Aureus Greenway Holdings Inc. announce $2.51M purchase order for drones in support of Department of War program

Powerus, through its subsidiary Tandem Defense, received a $2.51 million purchase order from a Department of War prime contractor for 1,500 U.S.-made FPV drones, pilot kits, and spare parts. The drones are manufactured domestically, compliant with NDAA and TAA, and delivery is expected within 60 days. The announcement coincides with Aureus Greenway…

Alico to Present at the 17th Annual Midwest IDEAS Investor Conference

Alico to Present at the 17th Annual Midwest IDEAS Investor Conference

Alico, Inc., a Florida-based agribusiness and land management company, announced that its CEO will present at the 17th Annual Midwest IDEAS Investor Conference. The presentation will highlight Alico's strategic transformation and diversified land operations across 47,300 acres in Florida following its 2025 restructuring. The company aims to leverag…

Bath & Body Works to Report Second Quarter Results on August 26, 2026

Bath & Body Works to Report Second Quarter Results on August 26, 2026

Bath & Body Works, Inc. (NYSE: BBWI) announced that it will report its financial results for the second quarter of 2026 before the market opens on August 26, 2026. The company will also host a conference call featuring CEO Daniel Heaf and interim CFO Tom Javitch to discuss the results and provide a business update. Supplemental materials will be av…